These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 11139320

  • 1. Mapping the HLA-A24-restricted T-cell epitope peptide from a tumour-associated antigen HER2 / neu: possible immunotherapy for colorectal carcinomas.
    Tanaka H, Tsunoda T, Nukaya I, Sette A, Matsuda K, Umano Y, Yamaue H, Takesako K, Tanimura H.
    Br J Cancer; 2001 Jan 05; 84(1):94-9. PubMed ID: 11139320
    [Abstract] [Full Text] [Related]

  • 2. Identification of HLA-A3-restricted cytotoxic T lymphocyte epitopes from carcinoembryonic antigen and HER-2/neu by primary in vitro immunization with peptide-pulsed dendritic cells.
    Kawashima I, Tsai V, Southwood S, Takesako K, Sette A, Celis E.
    Cancer Res; 1999 Jan 15; 59(2):431-5. PubMed ID: 9927058
    [Abstract] [Full Text] [Related]

  • 3. [Generation of HER2 specific, HLA-A24 restricted CTLs derived from a healthy donor].
    Mimura K, Kono K, Miyagawa N, Omata H, Sugai H, Fujii H.
    Gan To Kagaku Ryoho; 2004 Oct 15; 31(11):1795-6. PubMed ID: 15553718
    [Abstract] [Full Text] [Related]

  • 4. [Generation of HER2 specific, HLA-A24 restricted CTLs derived from gastric cancer patients].
    Mimura K, Kono K, Sugai H, Miyagawa N, Omata H, Fujii H, Matsumoto Y.
    Gan To Kagaku Ryoho; 2003 Oct 15; 30(11):1802-4. PubMed ID: 14619524
    [Abstract] [Full Text] [Related]

  • 5. Identification of antigenic epitopes recognized by Mac-2 binding protein-specific cytotoxic T lymphocytes in an HLA-A24 restricted manner.
    Kontani K, Teramoto K, Ozaki Y, Fujita T, Tezuka N, Sawai S, Watanabe H, Fujino S, Yokomise H, Ohkubo I.
    Int J Oncol; 2004 Dec 15; 25(6):1537-42. PubMed ID: 15547688
    [Abstract] [Full Text] [Related]

  • 6. Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53.
    Umano Y, Tsunoda T, Tanaka H, Matsuda K, Yamaue H, Tanimura H.
    Br J Cancer; 2001 Apr 20; 84(8):1052-7. PubMed ID: 11308253
    [Abstract] [Full Text] [Related]

  • 7. Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells.
    Koido S, Hara E, Homma S, Torii A, Toyama Y, Kawahara H, Watanabe M, Yanaga K, Fujise K, Tajiri H, Gong J, Toda G.
    Clin Cancer Res; 2005 Nov 01; 11(21):7891-900. PubMed ID: 16278414
    [Abstract] [Full Text] [Related]

  • 8. An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin.
    Hirohashi Y, Torigoe T, Maeda A, Nabeta Y, Kamiguchi K, Sato T, Yoda J, Ikeda H, Hirata K, Yamanaka N, Sato N.
    Clin Cancer Res; 2002 Jun 01; 8(6):1731-9. PubMed ID: 12060610
    [Abstract] [Full Text] [Related]

  • 9. A wild-type sequence p53 peptide presented by HLA-A24 induces cytotoxic T lymphocytes that recognize squamous cell carcinomas of the head and neck.
    Eura M, Chikamatsu K, Katsura F, Obata A, Sobao Y, Takiguchi M, Song Y, Appella E, Whiteside TL, DeLeo AB.
    Clin Cancer Res; 2000 Mar 01; 6(3):979-86. PubMed ID: 10741724
    [Abstract] [Full Text] [Related]

  • 10. Identification of a MAGE-2-encoded human leukocyte antigen-A24-binding synthetic peptide that induces specific antitumor cytotoxic T lymphocytes.
    Tahara K, Takesako K, Sette A, Celis E, Kitano S, Akiyoshi T.
    Clin Cancer Res; 1999 Aug 01; 5(8):2236-41. PubMed ID: 10473111
    [Abstract] [Full Text] [Related]

  • 11. Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma.
    Komori H, Nakatsura T, Senju S, Yoshitake Y, Motomura Y, Ikuta Y, Fukuma D, Yokomine K, Harao M, Beppu T, Matsui M, Torigoe T, Sato N, Baba H, Nishimura Y.
    Clin Cancer Res; 2006 May 01; 12(9):2689-97. PubMed ID: 16675560
    [Abstract] [Full Text] [Related]

  • 12. Immunization with a peptide epitope (p369-377) from HER-2/neu leads to peptide-specific cytotoxic T lymphocytes that fail to recognize HER-2/neu+ tumors.
    Zaks TZ, Rosenberg SA.
    Cancer Res; 1998 Nov 01; 58(21):4902-8. PubMed ID: 9809997
    [Abstract] [Full Text] [Related]

  • 13. Comparison of various sources of antigen-presenting cells for the generation of GP2-tumor peptide specific cytotoxic T-lymphocytes.
    Peiper M, Goedegebuure PS, Alldinger I, Knoefel WT, Izbicki JR, Eberlein TJ.
    Anticancer Res; 2002 Nov 01; 22(6A):3357-63. PubMed ID: 12530087
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial.
    Mittendorf EA, Storrer CE, Foley RJ, Harris K, Jama Y, Shriver CD, Ponniah S, Peoples GE.
    Cancer; 2006 Jun 01; 106(11):2309-17. PubMed ID: 16596621
    [Abstract] [Full Text] [Related]

  • 15. Host-oriented peptide evaluation using whole blood assay for generating antigen-specific cytotoxic T lymphocytes.
    Kawabuchi Y, Yamaguchi Y, Ohshita A, Minami K, Toge T.
    Anticancer Res; 2004 Jun 01; 24(2C):1193-200. PubMed ID: 15154646
    [Abstract] [Full Text] [Related]

  • 16. Identification of an epitope from the epithelial cell adhesion molecule eliciting HLA-A*2402-restricted cytotoxic T-lymphocyte responses.
    Tajima K, Demachi A, Ito Y, Nishida K, Akatsuka Y, Tsujimura K, Kuwano H, Mitsudomi T, Takahashi T, Kuzushima K.
    Tissue Antigens; 2004 Dec 01; 64(6):650-9. PubMed ID: 15546337
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dendritic cell-based immunotherapy of cancer with carcinoembryonic antigen-derived, HLA-A24-restricted CTL epitope: Clinical outcomes of 18 patients with metastatic gastrointestinal or lung adenocarcinomas.
    Ueda Y, Itoh T, Nukaya I, Kawashima I, Okugawa K, Yano Y, Yamamoto Y, Naitoh K, Shimizu K, Imura K, Fuji N, Fujiwara H, Ochiai T, Itoi H, Sonoyama T, Hagiwara A, Takesako K, Yamagishi H.
    Int J Oncol; 2004 Apr 01; 24(4):909-17. PubMed ID: 15010829
    [Abstract] [Full Text] [Related]

  • 20. Dendritic cells pulsed with HER-2/neu-derived peptides can induce specific T-cell responses in patients with gastric cancer.
    Kono K, Takahashi A, Sugai H, Fujii H, Choudhury AR, Kiessling R, Matsumoto Y.
    Clin Cancer Res; 2002 Nov 01; 8(11):3394-400. PubMed ID: 12429626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.